NASDAQ:FBIO

Fortress Biotech Stock Insider Trading

Healthcare > Biotechnology

Buy FBIO

*Your capital is at risk

$2.61

-0.0400 (-1.51%)

At Close: Jun 03, 2026

Fortress Biotech Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 24.95M and sold 20K FBIO shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	100.00
● Buy	24.95M shares
● Sell	20K shares
98% Buy Activity Negligible or No Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Apr 01, 2026 Buy	Common Stock, par value $0.001 A-Award	Jin David Chief Financial Officer	C-Suite Officer	2 967 Value: $6K
Mar 18, 2026 Buy	Common stock, par value $0.001 A-Award	Rosenwald Lindsay A Md President, CEO & Chairman	CEO / President	475 424 Value: $1.50M
Mar 18, 2026 Buy	common stock, par value $0.001 A-Award	Weiss Michael S Executive Vice Chairman	CEO / President	475 424 Value: $1.50M
Jan 01, 2026 Buy	common stock, par value $0.001 A-Award	Klein Dov Director	Director	27 322 Value: $71.3K
Jan 01, 2026 Buy	common stock, par value $0.001 A-Award	Harvey Jimmie Director	Director	27 322 Value: $71.3K
Jan 01, 2026 Buy	common stock, par value $0.001 A-Award	Lorenz Kevin Director	Director	27 322 Value: $71.3K
Jan 01, 2026 Buy	Common Stock, par value $0.001 A-Award	Hoenlein Malcolm Director	Director	27 322 Value: $71.3K
Jan 01, 2026 Buy	common stock, par value $0.001 A-Award	Lobell J Jay Director	Director	27 322 Value: $71.3K
Oct 01, 2025 Buy	Common Stock, par value $0.001 A-Award	Jin David Chief Financial Officer	C-Suite Officer	2 711 Value: $4K
Oct 01, 2025 Buy	Common Stock, par value $0.001 A-Award	Jin David Chief Financial Officer	C-Suite Officer	2 711 Value: $4K
Apr 01, 2025 Buy	Common Stock, par value $0.001 A-Award	Jin David Chief Financial Officer	C-Suite Officer	5 000 Value: $6K
Apr 01, 2025 Buy	Common Stock, par value $0.001 A-Award	Jin David Chief Financial Officer	C-Suite Officer	5 000 Value: $6K
Jan 01, 2025 Buy	common stock, par value $0.001 A-Award	Klein Dov Director	Director	49 383 Value: $128.9K
Jan 01, 2025 Buy	common stock, par value $0.001 A-Award	Lu Lucy Director	Director	49 383 Value: $128.9K
Jan 01, 2025 Buy	common stock, par value $0.001 A-Award	Harvey Jimmie Director	Director	49 383 Value: $128.9K
Jan 01, 2025 Buy	common stock, par value $0.001 A-Award	Lorenz Kevin Director	Director	49 383 Value: $128.9K
Jan 01, 2025 Buy	Common Stock, par value $0.001 A-Award	Hoenlein Malcolm Director	Director	49 383 Value: $128.9K
Jan 01, 2025 Buy	common stock, par value $0.001 A-Award	Weiss Michael S Executive Vice Chairman	CEO / President	454 153 Value: $1.19M
Jan 01, 2025 Buy	Common stock, par value $0.001 A-Award	Rosenwald Lindsay A Md President, CEO & Chairman	CEO / President	454 153 Value: $1.19M
Jan 01, 2025 Buy	Common stock, par value $0.001 A-Award	Rosenwald Lindsay A Md President, CEO & Chairman	CEO / President	454 153 Value: $1.19M
Jan 01, 2025 Buy	common stock, par value $0.001 A-Award	Weiss Michael S Executive Vice Chairman	CEO / President	454 153 Value: $1.19M
Jan 01, 2025 Buy	Common Stock, par value $0.001 A-Award	Hoenlein Malcolm Director	Director	49 383 Value: $128.9K
Jan 01, 2025 Buy	common stock, par value $0.001 A-Award	Lorenz Kevin Director	Director	49 383 Value: $128.9K
Jan 01, 2025 Buy	common stock, par value $0.001 A-Award	Harvey Jimmie Director	Director	49 383 Value: $128.9K
Jan 01, 2025 Buy	common stock, par value $0.001 A-Award	Lu Lucy Director	Director	49 383 Value: $128.9K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT FORTRESS BIOTECH

Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch symptoms; Ceracade for dry skin conditions; Luxamend for dressing and managing wounds; and Accutane capsules...

Read Full Profile Here